Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany

Drug budget and prescription control measures are implemented regionally in Germany, meaning that the uptake of pharmaceuticals, including biosimilars, can vary by region. We examine regional market dynamics of tumor necrosis factor alpha (TNFα) inhibitor originators and biosimilars in Germany and s...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Evelien Moorkens, Teresa Barcina Lacosta, Arnold G. Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert Selke, Isabelle Huys, Steven Simoens
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI AG 2020-10-01
Серии:Pharmaceuticals
Предметы:
infliximab
etanercept
TNFα inhibitors
biologics
biosimilars
Germany
Online-ссылка:https://www.mdpi.com/1424-8247/13/10/324
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы